-
Je něco špatně v tomto záznamu ?
Effects of the F-actin inhibitor latrunculin A on the budding yeast Saccharomyces cerevisiae
M. Kopecká, M. Yamaguchi, S. Kawamoto,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články
PubMed
25858300
DOI
10.1099/mic.0.000091
Knihovny.cz E-zdroje
- MeSH
- aktiny antagonisté a inhibitory MeSH
- antifungální látky farmakologie MeSH
- bicyklické sloučeniny heterocyklické farmakologie MeSH
- mikrobiální viabilita účinky léků MeSH
- mikroskopie MeSH
- počet mikrobiálních kolonií MeSH
- Saccharomyces cerevisiae cytologie účinky léků fyziologie MeSH
- Saccharomycetales cytologie účinky léků fyziologie MeSH
- thiazolidiny farmakologie MeSH
- Publikační typ
- časopisecké články MeSH
Our basic cell biology research was aimed at investigating the effect on eukaryotic cells of the sudden loss of the F-actin cytoskeleton. Cells treated with latrunculin A (LA) in yeast extract peptone dextrose (YEPD) medium were examined using phase-contrast and fluorescent microscopy, freeze-substitution, transmission and scanning electron microscopy, counted using a Bürker chamber and their absorbance measured. The cells responded to the presence of LA, an F-actin inhibitor, with the disappearance of actin patches, actin cables and actin rings. This resulted in the formation of larger spherical cells with irregular morphology in the cell walls and ultrastructural disorder of the cell organelles and secretory vesicles. Instead of buds, LA-inhibited cells formed only 'table-mountain-like' wide flattened swellings without apical growth with a thinner glucan cell-wall layer containing β-1,3-glucan microfibrils. The LA-inhibited cells lysed. Actin cables and patches were required for bud formation and bud growth. In addition, actin patches were required for the formation of β-1,3-glucan microfibrils in the bud cell wall. LA has fungistatic, fungicidal and fungilytic effects on the budding yeast Saccharomyces cerevisiae.
Department of Biology Faculty of Medicine Masaryk University Brno Czech Republic
Medical Mycology Research Centre Chiba University Chuo ku Japan
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16020895
- 003
- CZ-PrNML
- 005
- 20160803095620.0
- 007
- ta
- 008
- 160722s2015 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1099/mic.0.000091 $2 doi
- 024 7_
- $a 10.1099/mic.0.000091 $2 doi
- 035 __
- $a (PubMed)25858300
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Kopecká, Marie $u 1Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
- 245 10
- $a Effects of the F-actin inhibitor latrunculin A on the budding yeast Saccharomyces cerevisiae / $c M. Kopecká, M. Yamaguchi, S. Kawamoto,
- 520 9_
- $a Our basic cell biology research was aimed at investigating the effect on eukaryotic cells of the sudden loss of the F-actin cytoskeleton. Cells treated with latrunculin A (LA) in yeast extract peptone dextrose (YEPD) medium were examined using phase-contrast and fluorescent microscopy, freeze-substitution, transmission and scanning electron microscopy, counted using a Bürker chamber and their absorbance measured. The cells responded to the presence of LA, an F-actin inhibitor, with the disappearance of actin patches, actin cables and actin rings. This resulted in the formation of larger spherical cells with irregular morphology in the cell walls and ultrastructural disorder of the cell organelles and secretory vesicles. Instead of buds, LA-inhibited cells formed only 'table-mountain-like' wide flattened swellings without apical growth with a thinner glucan cell-wall layer containing β-1,3-glucan microfibrils. The LA-inhibited cells lysed. Actin cables and patches were required for bud formation and bud growth. In addition, actin patches were required for the formation of β-1,3-glucan microfibrils in the bud cell wall. LA has fungistatic, fungicidal and fungilytic effects on the budding yeast Saccharomyces cerevisiae.
- 650 _2
- $a aktiny $x antagonisté a inhibitory $7 D000199
- 650 _2
- $a antifungální látky $x farmakologie $7 D000935
- 650 _2
- $a bicyklické sloučeniny heterocyklické $x farmakologie $7 D019086
- 650 _2
- $a počet mikrobiálních kolonií $7 D015169
- 650 _2
- $a mikrobiální viabilita $x účinky léků $7 D050296
- 650 _2
- $a mikroskopie $7 D008853
- 650 _2
- $a Saccharomyces cerevisiae $x cytologie $x účinky léků $x fyziologie $7 D012441
- 650 _2
- $a Saccharomycetales $x cytologie $x účinky léků $x fyziologie $7 D004718
- 650 _2
- $a thiazolidiny $x farmakologie $7 D053778
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Yamaguchi, Masashi $u 2Medical Mycology Research Centre, Chiba University, Chuo-ku, Japan.
- 700 1_
- $a Kawamoto, Susumu $u 2Medical Mycology Research Centre, Chiba University, Chuo-ku, Japan.
- 773 0_
- $w MED00003340 $t Microbiology (Reading, England) $x 1465-2080 $g Roč. 161, č. 7 (2015), s. 1348-55
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25858300 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20160722 $b ABA008
- 991 __
- $a 20160803095850 $b ABA008
- 999 __
- $a ok $b bmc $g 1155565 $s 945423
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 161 $c 7 $d 1348-55 $e 20150409 $i 1465-2080 $m Microbiology $n Microbiology $x MED00003340
- LZP __
- $a Pubmed-20160722